Nonmedical prescription drug use among injection drug users

Journal of Drug Issues

Volumn 42, Issue 3, 2012, Pages 216-225

  Martinez, Alexis N ^a   D'Amico, Elizabeth J ^b   Kral, Alex H ^c,d   Bluthenthal, Ricky N ^e  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

^b RAND CORPORATION   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epidemiology; Injection drug users; Overdose; Prescription drug use; Substance abuse

Indexed keywords

EID: 84877852029     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/0022042612456015     Document Type: Article

References (31)

1. American Psychological Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Becker, W., Sullivan, L., Tetrault, J., Desai, R., & Fiellin, D. (2008). Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence, 94, 38-47.
3. Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007). Release from prison - A high risk of death for former inmates. New England Medical Journal, 356, 157-165.
4. Bluthenthal, R. N., Anderson, R., Flynn, N. M., & Kral, A. H. (2007). Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence, 84, 423-435.
5. Boyd, C. J., & McCabe, S. E. (2008). Coming to terms with the nonmedical use of prescription medications. Substance Abuse Treatment, Prevention and Policy, 3, 1-3.
6. Darke, S., Williamson, A., Ross, J., Mills, K. L., & Havard, A. T. (2007). Patterns of nonfatal heroin overdose over a 3-year period: Findings from the Australian treatment outcome study. Journal of Urban Health, 84, 283-291.
7. Darke, S. M., & Ross, J. (2000). The use of antidepressants among injecting drug users in Sydney, Australia. Addiction, 95, 407-417.
8. Davidson, P. J., McLean, R. L., Kral, A. H., Gleghorn, A. A., Edlin, B. R., & Moss, A. R. (2003). Fatal heroin-related overdose in San Francisco, 1997-2000: A case for targeted intervention. Journal of Urban Health, 80, 261-273.
9. Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J. K., Andersen, M., . . . Tortu, S. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1, 383-392.
10. Fast, D., Small, W., Wood, E., & Kerr, T. (2009). Coming "down here": Young people's reflections on becoming entrenched in a local drug scene. Social Science & Medicine, 69, 1204-1210.
11. Huang, B., Dawson, D., Stinson, F., Hasin, D., Ruan, W., Saha, T., . . . Grant, B. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 67, 1062-1073.
12. Kral, A. H., Anderson, R., Flynn, N., & Bluthenthal, R. N. (2004). Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes, 37, 1307-1312.
13. Kroutil, L., Van Brunt, D., Herman-Stahl, M., Heller, D., Bray, R., & Penne, M. (2006). Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence, 15, 135-143.
14. Lankenau, S. E., Sanders, B., Bloom, J. J., Hathazi, D. S., Alarcon, E., Tortu, S., & Clatts, M. (2007). Prevalence and patters of prescription drug misuse among young ketamine injectors. Journal of Drug Issues, 37, 717-736.
15. McCabe, S. E., Cranford, J. A., & West, B. T. (2008). Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addictive Behaviors, 33, 1297-1305.
16. Milloy, M. J. S., Kerr, T., Mathias, R., Zhang, R., Montaner, J. S., Tyndall, M., & Wood, E. (2008). Nonfatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. American Journal of Drug and Alcohol Abuse, 34, 499-509.
17. National Institute on Drug Abuse. (2005). Prescription drugs: Abuse and addiction. Bethesda, MD: National Institutes of Health.
18. Needle, R. N., Fisher, D. G., Weatherby, N., Chitwood, D., Brown, B., Cesari, H., . . . Braunsterin, M. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9, 242-250.
19. Novak, S., & Ball, J. (2006). The New DAWN report: Emergency department visits involving nonmedical use of selected pharmaceuticals (Vol. 23). Rockville, MD: SAMHSA.
20. Pollini, R. A., McCall, L., Mehta, S. H., Vlahov, D., & Strathdee, S. A. (1999). Non-fatal overdose and subsequent drug treatment among injection drug users. Drug and Alcohol Dependence, 83, 104-110.
21. Powis, B., Strang, J., Griffiths, P., Taylor, C., Williamson, S., Fountain, J., & Gossop, M. (1999). Selfreported overdose among injecting drug users in London: Extent and nature of the problem. Addiction, 94, 471-478.
22. Seal, K. H., Kral, A. H., Gee, L., Moore, L. D., Bluthenthal, R. N., Lorvick, J., & Edlin, B. R. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area (1998-1999). American Journal of Public Health, 91, 1842-1846.
23. Sees, K. L., Di Marino, M. E., Ruediger, N. K., Sweeney, C. T., & Shiffman, S. (2005). Non-medical use of oxycontin tablets in the United States. Journal of Pain & Palliative Care Pharmacotherapy, 19, 13-23.
24. Simpson, S., Krishnan, L., Kunik, M., & Ruiz, P. (2007). Racial disparities in diagnosis and treatment of depression: A literature review. Psychiatric Quarterly, 78, 3-14.
25. Sporer, K. A. (2003). Strategies for preventing heroin overdose. British Medical Journal, 326, 442-444.
26. Substance Abuse and Mental Health Services Administration. (2006). Drug-related emergency room visits. Rockville, MD: U.S. Department of Health and Human Services.
27. Wakeman, S. E., Bowman, S. E., McKenzie, M., Jeronimo, A., & Rich, J. D. (2009). Preventing death among the recently incarcerated: An argument for naloxone prescription before Release. Journal of Addictive Diseases, 28, 124-129.
28. Warner-Smith, M., Darke, S., & Day, C. (2002). Morbidity associated with non-fatal heroin overdose. Addiction, 97, 963-967.
29. Weatherby, N., Needle, R. H., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users recruited through street outreach. Evaluation and Program Planning, 17, 347-355.
30. Wells, K. R., Koike, A., & Sherbourne, C. (2001). Ethnic disparities in unmet need for alcoholism, drug abuse and mental health care. American Journal of Psychology, 158, 2027-2032.
31. Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., & Sannerund, C. (2003). College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence, 69, 215-232.